Mobile app designed to help parents of NICU-babies cope

Researchers have designed a smartphone app for parents with very low-birth-weight infants to help them better transition home from the hospital.

Developed by researchers at the Northwestern University Feinberg School of Medicine, the app—called NICU-2-Home—manages infants’ health data, educates the parents on common NICU issues and supports mothers’ and fathers’ mental health.

Craig Garfield, MD, associate professor in pediatrics-hospital based medicine and medical social sciences, and his colleagues had interviewed 25 parents with very low-birth-weight infants to help inform the app’s development, according to a study published in Journal of Perinatal & Neonatal Nursing.

They had wanted to determine the parents’ concerns and their coping mechanisms for the period following discharge from the hospital.

“It was really eye-opening to discover what we called in the paper ‘pervasive uncertainty,’ the uncertainty parents describe across nearly all of their abilities to care for their very low birth weight infants at home,” Garfield said in a statement.

His team currently is embarking on a randomized feasibility trial in the NICU to see if the app could have a measureable impact on parenting.

Access the study here.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.